INVESTORS
RFPi offers a ground-floor opportunity for investors to be part of bringing a breakthrough technology to market. Learn more about our market opportunities and how you can become a partner.
PHYSICIANS
The ability to visualize and understand the vascular integrity of tissues is previously unavailable information in real time during procedures. See how our iCertainty non-invasive technology can quantify the physiology of blood flow and perfusion where knowledge of that information could improve outcomes.
HOSPITAL MANAGEMENT
An improvement in technical outcomes may result in fewer complications, shorter hospital stays and reduced readmissions. Translation: the possibility of overall reduced health system costs and enhanced patient care.
NEWS
September 9, 2019 –RFPi Receives Federal Grant to Develop Novel Evaluation Tool for Asymptomatic Patients at Risk for Peripheral Arterial Disease
January 10, 2019 – RFPi Receives FDA Clearance to Market iCertainty™ — A Real-Time, Non-Invasive, Non-Contact Blood Flow Imaging Medical Device
June 1, 2018 – RFPI among 50 early- and mid-stage companies chosen for MedTech Innovator
January 23, 2018 – RFPI has been selected to present at The Council for Entrepreneurial Development’s 27th annual CED Life Science Conference
EVENTS
SAGES - Society of American Gastrointestinal and Endoscopic Surgeons - April 3-4, Baltimore, MD RFPi Chief Medical Officer, Bruce Ferguson, MD and CEO Jeff Basham will be attending SAGES meeting in Baltimore. Dr. Ferguson has had an RFPi poster accepted and will present at the SAGES i3 Summit, “Bringing innovators, investors, and industry together to foster innovative and emerging technologies that benefit patients.”
J.P.Morgan Healthcare Conference January 7-10, 2019